All Industries

Top Genomics Companies

254 Genomics companies, sorted by total funding raised.

Alterome TherapeuticsAcquired

Develops potentially safer, more precise therapies for aggressive cancers lacking effective optio...

San Diego, United States11–50Biotech, Genomics
Series BTotal funding$231.0MApr 2024
DalCor Pharmaceuticals

DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic p...

Drug Discovery, Genomics
Series DTotal funding$230.0MSep 2023
PMV PharmaIPO

Precision oncology company developing first-in-class small molecule therapies that reactivate mut...

Princeton, United States11–50Biotech, Genomics
Series DTotal funding$206.0MAug 2020
Scipher Medicine

Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...

Boston, United States51–200Artificial Intelligence, Drug Discovery
Series DTotal funding$197.8MJul 2024
SpliceBio

SpliceBio develops next-generation gene therapies using its proprietary Protein Splicing platform...

Barcelona, Spain11–50Biotech, Drug Discovery
Series BTotal funding$192.0MJun 2025
Genome Medical

Telehealth genetic counseling and test-support for patients, providers, and life-sciences partner...

South San Francisco, United States51–200Digital Health, Genomics
Series DTotal funding$183.3MOct 2024
Black Diamond TherapeuticsIPO

Black Diamond discovers and develops next-wave precision cancer medicines to treat patients with ...

Cambridge, United States51–200Biotech, Genomics
Series CTotal funding$170.0MDec 2019
AviadoBio

AviadoBio is a biotechnology company developing transformative gene therapies for neurodegenerati...

London, United Kingdom51–200Biotech, Genomics
Series BTotal funding$168.5MApr 2025
Editas MedicineIPO

Editas Medicine is building a leading gene editing company that uses CRISPR genome editing to dev...

Cambridge, United States201–500Biotech, Genomics
Series BTotal funding$163.0MAug 2015
AkouosAcquired

Akouos advances precision genetic therapies with the potential to restore, improve, and preserve ...

Boston, United States51–200Biotech, Therapeutics
Series BTotal funding$162.5MMar 2020
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Series BTotal funding$155.5MSep 2026
Avencell

AvenCell is a clinical-stage cell therapy company developing controllable, allogeneic CAR-T thera...

Watertown, United States51–200Biotech, Genomics
GrantTotal funding$152.0MJun 2025
Clear Labs

Clear Labs provides food analytics while standardizing molecular food quality the global molecula...

San Francisco, United States51–200Biotech, Diagnostics
Series DTotal funding$150.2MDec 2024
Elephas Biosciences

Elephas Biosciences' elive™ platform is designed to provide real-time functional response predict...

Madison, United States51–200Biotech, Genomics
Extension RoundTotal funding$136.5MNov 2025
SalioGen Therapeutics
Biotech, Genomics
Series BTotal funding$135.0MJan 2022
OmniomeAcquired

Develops a short-read DNA sequencing platform (Sequencing by Binding) offering high accuracy for ...

San Diego, United States51–200Biotech, Genomics
Series CTotal funding$133.0MJan 2020
Pretzel Therapeutics

Develops therapeutics that restore mitochondrial function for rare and common diseases using geno...

Waltham, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$131.8MAug 2024
Berry GenomicsIPO

Leading Chinese genomics company specializing in NGS-based genetic testing for reproductive healt...

Beijing, China201–500Healthcare, Genomics
Series BTotal funding$129.8MJan 2020
Agendia

Molecular diagnostics company focused solely on breast cancer, developing and commercializing per...

Irvine, United StatesBiotech, Diagnostics
Growth EquityTotal funding$123.0MJul 2018
MISSION BIO INC

R&D company with 7 SBIR/STTR awards from Department of Health and Human Services, National Scienc...

South San Francisco, United States1–10Biotech, Healthcare
Venture RoundTotal funding$110.0MAug 2025
Singular GenomicsAcquired

Singular Genomics maps molecules and cells directly in tissue through high-throughput spatial mul...

La Jolla, United States201–500Genomics, Life Sciences
Venture RoundTotal funding$104.0MFeb 2021
Variantyx

Molecular diagnostics lab providing whole-genome-based genetic testing for rare disorders, reprod...

Boston, United States51–200Diagnostics, Genomics
Series DTotal funding$100.0MApr 2024
Embark Veterinary

Consumer dog DNA testing company providing breed identification, ancestry, and health screening.

Boston, United States1–10Genomics, Healthcare
Series BTotal funding$91.1MJul 2021
Qihan Biotech

Genome editing biotechnology company with world-leading capabilities in multiplexable genome edit...

Hangzhou, ChinaBiotech, Genomics
Venture RoundTotal funding$90.8MSep 2023
Gigagen, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

South San Francisco, United States1–10Biotech, Genomics
Corporate RoundTotal funding$90.0MMar 2021